Clinical outcomes following ibrutinib and idelalisib-based therapy in CLL: A retrospective analysis

July 20, 2017

Type of Cancer

Lymphoma

Site

Hackensack

Sponsor

Hackensack UMC

Protocol Number

Hackensack UMC PRO 00005855

To Learn More Call

(201)-510-0950